Remote Therapeutic Monitoring in Rheumatic and Musculoskeletal Diseases: Opportunities and Implementation
- PMID: 38550526
- PMCID: PMC10972608
- DOI: 10.18103/mra.v11i7.2.3957
Remote Therapeutic Monitoring in Rheumatic and Musculoskeletal Diseases: Opportunities and Implementation
Abstract
Therapeutic Monitoring (RTM) is a new program in the United States that began in 2022 allowing electronic patient-reported outcomes (ePRO) and other patient-generated data to be reviewed by clinical staff between visits so that patients can receive clinical attention as needed. Remote Therapeutic Monitoring simultaneously enhances the capacity to generate prospective longitudinal data that may be useful for secondary research purposes. As many governmental and private insurance programs in the United States now provide reimbursement for Remote Therapeutic Monitoring, increasing numbers of rheumatologists may be incentivized to provide this service for their patient populations. Launched in 2015, the ArthritisPower® Research Registry and associated mobile and desktop application, registered with the Food & Drug Administration (FDA) as a Class I medical device, enables patients to track their disease across dozens of domains and to securely participate in voluntary research studies. ArthritisPower, in partnership with Illumination Health, has developed infrastructure and a clinical workflow for Remote Therapeutic Monitoring that will help rheumatologists more closely track their patients' disease activity and flares, identify primary non-adherence, record changes in key health domains (e.g. fatigue, pain, physical function, mental health) and meet the needs for other data elements important for clinical care identified by individual providers. Ultimately, the approach to use digital health tools between visits seeks to improve clinical outcomes for patients with rheumatic and musculoskeletal diseases. This editorial review discusses the evolution of remote monitoring in rheumatologic care, describes the opportunities for physician reimbursement as of 2023, and provides a suggested workflow in order to establish Remote Therapeutic Monitoring within rheumatology practices.
Keywords: Ankylosing Spondylitis; Patient-Reported Outcomes; Psoriatic Arthritis; Rheumatoid Arthritis; Telemedicine.
Conflict of interest statement
Conflict of Interest Statement Financial interests of the authors which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work are as follows: • WBN is Principal Investigator on grants/contracts from AbbVie, Amgen, Janssen and Scipher Medicine, and an employee of the Global Healthy Living Foundation (GHLF). GHLF receives grants, sponsorships and contracts from pharmaceutical manufacturers and private foundations. A full list of GHLF funders is publicly available here: https://www.ghlf.org/our-partners/. • JRC receives research grants and consulting fees from AbbVie, AQTUAL, Amgen, BMS, CorEvitas, Eli Lilly and Company, GSK, Janssen, Novartis, Pfizer, Sanofi, Scipher Medicine, TNacity Blue Ocean and UCB; Dr. Curtis receives consulting fees from Gilead and Samsung.
Figures
Similar articles
-
Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study.JMIR Res Protoc. 2024 Apr 22;13:e55829. doi: 10.2196/55829. JMIR Res Protoc. 2024. PMID: 38501508 Free PMC article.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial.JMIR Res Protoc. 2023 Dec 27;12:e52872. doi: 10.2196/52872. JMIR Res Protoc. 2023. PMID: 38150310 Free PMC article.
-
Remote monitoring for long-term physical health conditions: an evidence and gap map.Health Soc Care Deliv Res. 2023 Nov;11(22):1-74. doi: 10.3310/BVCF6192. Health Soc Care Deliv Res. 2023. PMID: 38014553
-
Digital Interventions to Build a Patient Registry for Rheumatology Research.Rheum Dis Clin North Am. 2019 May;45(2):173-186. doi: 10.1016/j.rdc.2019.01.009. Rheum Dis Clin North Am. 2019. PMID: 30952391 Review.
Cited by
-
Randomized controlled trials of digital health interventions for rheumatic disease management: a systematic review.Bull World Health Organ. 2025 Feb 1;103(2):136-147. doi: 10.2471/BLT.24.292168. Epub 2024 Dec 11. Bull World Health Organ. 2025. PMID: 39882494 Free PMC article.
-
Trends in utilization of remote monitoring in the United States.Health Aff Sch. 2025 Jun 6;3(6):qxaf115. doi: 10.1093/haschl/qxaf115. eCollection 2025 Jun. Health Aff Sch. 2025. PMID: 40575760 Free PMC article.
-
Reviewing the Advances in Remote Therapeutic and Physiological Monitoring and Applicability for Chronic Pain Management.J Pain Res. 2025 Jul 30;18:3757-3764. doi: 10.2147/JPR.S530553. eCollection 2025. J Pain Res. 2025. PMID: 40756433 Free PMC article. Review.
-
Wearable activity tracker study exploring rheumatoid arthritis patients' disease activity using patient-reported outcome measures, clinical measures, and biometric sensor data (the wear study).Contemp Clin Trials Commun. 2024 Feb 27;38:101272. doi: 10.1016/j.conctc.2024.101272. eCollection 2024 Apr. Contemp Clin Trials Commun. 2024. PMID: 38444876 Free PMC article.
References
-
- GlobeNewswire. G Medical Innovations and MiCare Path Announce Joint Collaboration to Provide Innovative Remote Patient Monitoring Solutions Globally. 2023.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials